对乙酰氨基酚过量临床管理的目标生物标志物概况
Target biomarker profile for the clinical management of paracetamol overdose.
作者信息
Vliegenthart A D Bastiaan, Antoine Daniel J, Dear James W
机构信息
Pharmacology, Toxicology & Therapeutics, University/BHF Centre for Cardiovascular Science, University of Edinburgh, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh.
MRC Centre for Drug Safety Science, Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
出版信息
Br J Clin Pharmacol. 2015 Sep;80(3):351-62. doi: 10.1111/bcp.12699. Epub 2015 Jul 29.
Abstract
Paracetamol (acetaminophen) overdose is one of the most common causes of acute liver injury in the Western world. To improve patient care and reduce pressure on already stretched health care providers new biomarkers are needed that identify or exclude liver injury soon after an overdose of paracetamol is ingested. This review highlights the current state of paracetamol poisoning management and how novel biomarkers could improve patient care and save healthcare providers money. Based on the widely used concept of defining a target product profile, a target biomarker profile is proposed that identifies desirable and acceptable key properties for a biomarker in development to enable the improved treatment of this patient population. The current biomarker candidates, with improved hepatic specificity and based on the fundamental mechanistic basis of paracetamol-induced liver injury, are reviewed and their performance compared with our target profile.
摘要
对乙酰氨基酚过量是西方世界急性肝损伤最常见的原因之一。为改善患者护理并减轻本就不堪重负的医疗服务提供者的压力，需要新的生物标志物，以便在摄入过量对乙酰氨基酚后不久就能识别或排除肝损伤。本综述重点介绍了对乙酰氨基酚中毒管理的现状，以及新型生物标志物如何改善患者护理并为医疗服务提供者节省资金。基于广泛使用的定义目标产品概况的概念，提出了一个目标生物标志物概况，该概况确定了正在开发的生物标志物的理想和可接受的关键特性，以改善对这一患者群体的治疗。本文回顾了目前具有更高肝脏特异性且基于对乙酰氨基酚诱导肝损伤基本机制的生物标志物候选物，并将它们的性能与我们的目标概况进行了比较。
相似文献
1
Target biomarker profile for the clinical management of paracetamol overdose.对乙酰氨基酚过量临床管理的目标生物标志物概况
Br J Clin Pharmacol. 2015 Sep;80(3):351-62. doi: 10.1111/bcp.12699. Epub 2015 Jul 29.
2
Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies.对乙酰氨基酚过量使用后使用机制生物标志物进行危险分层：两项前瞻性队列研究的结果。
Lancet Gastroenterol Hepatol. 2018 Feb;3(2):104-113. doi: 10.1016/S2468-1253(17)30266-2. Epub 2017 Nov 14.
3
Risk prediction of hepatotoxicity in paracetamol poisoning.对乙酰氨基酚中毒时肝毒性的风险预测
Clin Toxicol (Phila). 2017 Sep;55(8):879-892. doi: 10.1080/15563650.2017.1317349. Epub 2017 Apr 27.
4
Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.机制生物标志物可在首次就诊时提供对乙酰氨基酚引起的急性肝损伤的早期和敏感检测。
Hepatology. 2013 Aug;58(2):777-87. doi: 10.1002/hep.26294. Epub 2013 Jul 2.
5
External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose.对乙酰氨基酚-转氨酶乘积预测对乙酰氨基酚过量所致肝毒性的外部验证
Clin Toxicol (Phila). 2015;53(8):807-14. doi: 10.3109/15563650.2015.1066507. Epub 2015 Jul 15.
6
Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).细胞角蛋白 18 是一种敏感的生物标志物，可用于监测丙氨酸氨基转移酶升高，该标志物来自安慰剂对照、随机、交叉试验的治疗性扑热息痛剂量（PATH-BP 生物标志物子研究）。
Toxicol Sci. 2024 May 28;199(2):203-209. doi: 10.1093/toxsci/kfae031.
7
Nomogram line crossing after acetaminophen combination product overdose.对乙酰氨基酚复方制剂过量后的列线图线交叉
Clin Toxicol (Phila). 2016;54(1):40-6. doi: 10.3109/15563650.2015.1110591. Epub 2015 Nov 15.
8
Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose.对乙酰氨基酚-氨基转移酶乘积预测缓释型对乙酰氨基酚过量所致肝毒性的准确性。
Clin Toxicol (Phila). 2017 Jun;55(5):346-351. doi: 10.1080/15563650.2017.1290253. Epub 2017 Feb 15.
9
Intravenous Paracetamol Overdose: A Pediatric Case Report.静脉注射对乙酰氨基酚过量：一例儿科病例报告
Pediatr Emerg Care. 2019 Feb;35(2):e42-e43. doi: 10.1097/PEC.0000000000001432.
10
A descriptive analysis of aspartate and alanine aminotransferase rise and fall following acetaminophen overdose.对乙酰氨基酚过量服用后天冬氨酸氨基转移酶和丙氨酸氨基转移酶升降情况的描述性分析。
Clin Toxicol (Phila). 2015 Nov;53(9):849-55. doi: 10.3109/15563650.2015.1077968. Epub 2015 Aug 20.
引用本文的文献
1
Smartphone Biosensors for Non-Invasive Drug Monitoring in Saliva.用于唾液中非侵入性药物监测的智能手机生物传感器。
Biosensors (Basel). 2025 Mar 4;15(3):163. doi: 10.3390/bios15030163.
2
BMP6 participates in the molecular mechanisms involved in APAP hepatotoxicity.骨形态发生蛋白6参与了对乙酰氨基酚肝毒性相关的分子机制。
Arch Toxicol. 2025 Mar;99(3):1187-1202. doi: 10.1007/s00204-024-03954-5. Epub 2025 Jan 19.
3
Evaluation of capillary miR-122 as a prognostic biomarker of paracetamol-induced liver toxicity.评估毛细血管 miR-122 作为对乙酰氨基酚诱导的肝毒性的预后生物标志物。
Mol Biol Rep. 2024 Apr 20;51(1):548. doi: 10.1007/s11033-024-09327-6.
4
EGR1 is crucial for the chlorogenic acid-provided promotion on liver regeneration and repair after APAP-induced liver injury.EGR1 对于绿原酸在 APAP 诱导的肝损伤后促进肝脏再生和修复至关重要。
Cell Biol Toxicol. 2023 Dec;39(6):2685-2707. doi: 10.1007/s10565-023-09795-9. Epub 2023 Feb 21.
5
Mass Spectrometry-Based Proteomics Reveal Alcohol Dehydrogenase 1B as a Blood Biomarker Candidate to Monitor Acetaminophen-Induced Liver Injury.基于质谱的蛋白质组学研究揭示，醇脱氢酶 1B 是监测对乙酰氨基酚诱导肝损伤的血液生物标志物候选物。
Int J Mol Sci. 2021 Oct 14;22(20):11071. doi: 10.3390/ijms222011071.
6
A general model for cell death and biomarker release from injured tissues.一种损伤组织细胞死亡和生物标志物释放的通用模型。
J Pharmacokinet Pharmacodyn. 2021 Feb;48(1):69-82. doi: 10.1007/s10928-020-09720-1. Epub 2020 Sep 29.
7
HMGB1 is a Central Driver of Dynamic Pro-inflammatory Networks in Pediatric Acute Liver Failure induced by Acetaminophen.HMGB1 是乙酰氨基酚诱导的小儿暴发性肝衰竭中动态促炎网络的核心驱动因素。
Sci Rep. 2019 Apr 12;9(1):5971. doi: 10.1038/s41598-019-42564-5.
8
Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury.基于循环和成像的新型生物标志物，以增强对人类药物性肝损伤的机制理解。
J Clin Transl Res. 2017 Feb 12;3(1):199-211. eCollection 2017 Feb 17.
9
Hepatoprotective Effect of Ugonin M, A Constituent, on Acetaminophen-Induced Acute Liver Injury in Mice.乌骨宁 M 对乙酰氨基酚诱导的小鼠急性肝损伤的保护作用。
Molecules. 2018 Sep 21;23(10):2420. doi: 10.3390/molecules23102420.
10
Association of antioxidant nutraceuticals and acetaminophen (paracetamol): Friend or foe?抗氧化营养保健品与对乙酰氨基酚（扑热息痛）联合应用：是敌是友？
J Food Drug Anal. 2018 Apr;26(2S):S78-S87. doi: 10.1016/j.jfda.2017.11.004. Epub 2017 Dec 16.
本文引用的文献
1
Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury.循环中的肾损伤分子1可预测对乙酰氨基酚所致肝损伤患者的预后及不良结局。
Hepatology. 2015 Aug;62(2):591-9. doi: 10.1002/hep.27857. Epub 2015 May 29.
2
Acetaminophen Adducts Detected in Serum of Pediatric Patients With Acute Liver Failure.在急性肝衰竭儿科患者血清中检测到对乙酰氨基酚加合物。
J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):102-7. doi: 10.1097/MPG.0000000000000814.
3
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.HMGB1/RAGE轴在坏死之后引发中性粒细胞介导的损伤放大。
J Clin Invest. 2015 Feb;125(2):539-50. doi: 10.1172/JCI76887. Epub 2014 Dec 22.
4
The clinical liver safety assessment best practices workshop: rationale, goals, accomplishments and the future.临床肝脏安全性评估最佳实践研讨会：基本原理、目标、成果与未来。
Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S1-7. doi: 10.1007/s40264-014-0181-8.
5
Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.血肾损伤分子-1是急性和慢性肾损伤的生物标志物，并可预测I型糖尿病患者进展为终末期肾病的情况。
J Am Soc Nephrol. 2014 Oct;25(10):2177-86. doi: 10.1681/ASN.2013070758. Epub 2014 Jun 5.
6
Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260.肝脏生物标志物和体外评估证实，在接受 GABA A 受体拮抗剂 NP260 治疗的比格犬中，缺乏组织病理学相关性的转氨酶升高来源于肝脏。
Toxicol Appl Pharmacol. 2014 Jun 1;277(2):131-7. doi: 10.1016/j.taap.2014.03.015. Epub 2014 Mar 31.
7
Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment.英国对乙酰氨基酚中毒管理指南修订对住院人数、不良反应及治疗费用的影响。
Br J Clin Pharmacol. 2014 Sep;78(3):610-8. doi: 10.1111/bcp.12362.
8
Retro-orbital blood acquisition facilitates circulating microRNA measurement in zebrafish with paracetamol hepatotoxicity.眶后采血有助于检测对乙酰氨基酚肝毒性斑马鱼的循环微小RNA。
Zebrafish. 2014 Jun;11(3):219-26. doi: 10.1089/zeb.2013.0912. Epub 2014 Mar 13.
9
Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.重症监护病房患者循环线粒体 DNA 作为死亡率标志物的推导和验证。
PLoS Med. 2013 Dec;10(12):e1001577; discussion e1001577. doi: 10.1371/journal.pmed.1001577. Epub 2013 Dec 31.
10
Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects.血浆线粒体 DNA DAMPs 水平升高与严重创伤人类患者的临床结局相关。
Ann Surg. 2013 Oct;258(4):591-6; discussion 596-8. doi: 10.1097/SLA.0b013e3182a4ea46.
Zotero 插件